Cargando…

The relationship between monoamine oxidase B (MAOB) A644G polymorphism and Parkinson disease risk: a meta-analysis

BACKGROUND AND OBJECTIVES: Many studies were conducted to assess the relationship between Monoamine oxidase B (MAOB) A644G polymorphism and susceptibility to Parkinson disease (PD). However, the results were inconsistent and inconclusive. DESIGN AND SETTINGS: A meta-analysis was conducted from all p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Ying, Wang, Zhiyun, Zhang, Benshu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	King Faisal Specialist Hospital and Research Centre 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6074924/ https://www.ncbi.nlm.nih.gov/pubmed/24658549 http://dx.doi.org/10.5144/0256-4947.2014.12

Ejemplares similares

The Pathological Role of Astrocytic MAOB in Parkinsonism Revealed by Genetic Ablation and Over-expression of MAOB
por: An, Heeyoung, et al.
Publicado: (2021)

Platelet Serotonin (5-HT) Concentration, Platelet Monoamine Oxidase B (MAO-B) Activity and HTR2A, HTR2C, and MAOB Gene Polymorphisms in Asthma
por: Konjevod, Marcela, et al.
Publicado: (2023)

Revisiting the Role of Astrocytic MAOB in Parkinson’s Disease
por: Nam, Min-Ho, et al.
Publicado: (2022)

Functional MAOB Gene Intron 13 Polymorphism Predicts Dyskinesia in Parkinson's Disease
por: Löhle, Matthias, et al.
Publicado: (2022)

Relationships of Cerebrospinal Fluid Alzheimer’s Disease Biomarkers and COMT, DBH, and MAOB Single Nucleotide Polymorphisms
por: Babić Leko, Mirjana, et al.
Publicado: (2020)

Monoamine oxidase B rs1799836 G allele polymorphism is a risk factor for early development of levodopa-induced dyskinesia in Parkinson's disease
por: Kakinuma, Shoko, et al.
Publicado: (2020)

Monoamine Oxidase-B Inhibitors for the Treatment of Parkinson’s Disease: Past, Present, and Future
por: Tan, Yu-Yan, et al.
Publicado: (2022)

Monoamine oxidase-B (MAO-B) inhibitors: implications for disease-modification in Parkinson’s disease
por: Teo, Kay Cheong, et al.
Publicado: (2013)

Androgen receptor and monoamine oxidase polymorphism in wild bonobos
por: Garai, Cintia, et al.
Publicado: (2014)

The Association between a MAOB Variable Number Tandem Repeat Polymorphism and Cocaine and Opiate Addictions in Polyconsumers
por: Mateu, César, et al.
Publicado: (2021)

Neuroprotective Function of Rasagiline and Selegiline, Inhibitors of Type B Monoamine Oxidase, and Role of Monoamine Oxidases in Synucleinopathies
por: Naoi, Makoto, et al.
Publicado: (2022)

Monoamine Oxidase A and B Gene Polymorphisms and Negative and Positive Symptoms in Schizophrenia
por: Camarena, Beatriz, et al.
Publicado: (2012)

Efficacy, safety, and patient preference of monoamine oxidase B inhibitors in the treatment of Parkinson’s disease
por: Robottom, Bradley J
Publicado: (2011)

Monoamine Oxidase B in Renal Cell Carcinoma
por: Hodorová, Ingrid, et al.
Publicado: (2018)

Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors
por: Chiuccariello, Lina, et al.
Publicado: (2015)

The effect of monoamine oxidase-B inhibitors on the alleviation of depressive symptoms in Parkinson’s disease: meta-analysis of randomized controlled trials
por: Huang, Yao Hsien, et al.
Publicado: (2021)

Multiscale Modeling of Two-Photon Probes for Parkinson’s Diagnostics Based on Monoamine Oxidase B Biomarker
por: Murugan, N. Arul, et al.
Publicado: (2020)

Different Generations of Type-B Monoamine Oxidase Inhibitors in Parkinson’s Disease: From Bench to Bedside
por: Alborghetti, Marika, et al.
Publicado: (2019)

ABUSE OF MONOAMINE OXIDASE INHIBITORS
por: Ananth, Jambur, et al.
Publicado: (1995)

Monoamine Oxidase A Gene Polymorphisms and Bipolar Disorder in Iranian Population
por: Eslami Amirabadi, Mohammad Reza, et al.
Publicado: (2015)

Structure-Activity Relationship Analysis of 3-Phenylcoumarin-Based Monoamine Oxidase B Inhibitors
por: Rauhamäki, Sanna, et al.
Publicado: (2018)

Association between monoamine oxidase A promoter polymorphism and the risk of sudden infant death syndrome: a meta-analysis
por: Zhou, Qiaoxia, et al.
Publicado: (2021)

Age-Related Behavioral Phenotype of an Astrocytic Monoamine Oxidase-B Transgenic Mouse Model of Parkinson’s Disease
por: Lieu, Christopher A., et al.
Publicado: (2013)

Monoamine-oxidase Type B Inhibitors and Cognitive Functions in Parkinson’s Disease: Beyond the Primary Mechanism of Action
por: Rinaldi, Domiziana, et al.
Publicado: (2023)

No Association between the rs1799836 Polymorphism of the Monoamine Oxidase B Gene and the Risk of Autism Spectrum Disorders in the Kazakhstani Population
por: Perfilyeva, Anastassiya V., et al.
Publicado: (2019)

MAOB rs3027452 Modifies Mood Improvement After Tryptophan Supplementation
por: Gonzalez, Irene, et al.
Publicado: (2021)

Amphetamine Derivatives as Monoamine Oxidase Inhibitors
por: Reyes-Parada, Miguel, et al.
Publicado: (2020)

Parameters for Irreversible Inactivation of Monoamine Oxidase
por: Ramsay, Rona R., et al.
Publicado: (2020)

Comparative effectiveness of dopamine agonists and monoamine oxidase type-B inhibitors for Parkinson’s disease: a multiple treatment comparison meta-analysis
por: Binde, Caroline D., et al.
Publicado: (2020)

The Role of Single Nucleotide Polymorphisms of Monoamine Oxidase B, Dopamine D2 Receptor, and DOPA Decarboxylase Receptors Among Patients Treated for Parkinson’s Disease
por: Zapała, Barbara, et al.
Publicado: (2022)

Questionable association between a monoamine oxidase A promoter polymorphism and sudden infant death syndrome
por: Klintschar, Michael, et al.
Publicado: (2010)

Regulation of B family DNA polymerase fidelity by a conserved active site residue: characterization of M644W, M644L and M644F mutants of yeast DNA polymerase ε
por: Pursell, Zachary F., et al.
Publicado: (2007)

Exploration of the Detailed Structure–Activity Relationships of Isatin and Their Isomers As Monoamine Oxidase Inhibitors
por: Kumar, Sunil, et al.
Publicado: (2022)

Monoamine oxidase B is associated with γ-secretase in cultured neurons and in brain
por: Weiss, Sophia Schedin, et al.
Publicado: (2013)

Natural Products Screening for the Identification of Selective Monoamine Oxidase-B Inhibitors
por: Zarmouh, Najla O., et al.
Publicado: (2016)

Selectivity of Dietary Phenolics for Inhibition of Human Monoamine Oxidases A and B
por: Zhang, Zhenxian, et al.
Publicado: (2019)

Halogenated Coumarin–Chalcones as Multifunctional Monoamine Oxidase-B and Butyrylcholinesterase Inhibitors
por: Rehuman, Nisha Abdul, et al.
Publicado: (2021)

Effects of sevoflurane anaesthesia on radioligand binding to monoamine oxidase-B in vivo
por: Varnäs, Katarina, et al.
Publicado: (2021)

Promising Non-cytotoxic Monosubstituted Chalcones to Target Monoamine Oxidase-B
por: Iacovino, Luca G., et al.
Publicado: (2021)

Phenethylamine is a substrate of monoamine oxidase B in the paraventricular thalamic nucleus
por: Obata, Youhei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_27pkkrvq4q1mr304b3prrlbl1c